Daniel Lavin is a BioPharma Subject Matter Expert at Exyte, with extensive experience in the BioPharma and Life Sciences sectors. Previously, Daniel served as the Director of Program Management at Curia, managing a significant $110M facility expansion program. As Principal at Bioprocess Design and Technology Management, Daniel provided engineering and qualification consulting services. Daniel has held leadership roles in engineering and maintenance at NantKwest, managed process engineering at Shire, and led design and construction projects at Parsons. With a background in process development at Acusphere and experience as a Research Scientist at Repligen Corporation, Daniel holds a BS in Chemical Engineering from Bucknell University and further education from the University of Minnesota.
This person is not in any teams
This person is not in any offices